-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KO/P3HhosiHeyh5V+jbCtB+w7ZgVSnK7mo0Us014FtR4BVDopgWHcUXhgkoDsEOS fTgeh+sS7o0w6hkHScTcAA== 0001005477-00-000802.txt : 20000211 0001005477-00-000802.hdr.sgml : 20000211 ACCESSION NUMBER: 0001005477-00-000802 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000101 FILED AS OF DATE: 20000210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENDOREX CORP CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-16929 FILM NUMBER: 531253 BUSINESS ADDRESS: STREET 1: 28101 BALLARD DR. CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 847-573-8990 MAIL ADDRESS: STREET 1: 28101 BALLARD DR. CITY: LAKE FOREST STATE: IL ZIP: 60045 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 COMPANY DATA: COMPANY CONFORMED NAME: ARIES FINANCIAL SERVICES INC CENTRAL INDEX KEY: 0001007000 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128324379 4 1 FORM 4 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |_| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ================================================================================ 1. Name and Address of Reporting Person* Paramount Capital Asset Management, Inc. - -------------------------------------------------------------------------------- (Last) (First) (Middle) 787 Seventh Avenue, 48th Floor - -------------------------------------------------------------------------------- (Street) New York NY 10019 - -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol Endorex Corp. (DOR) ================================================================================ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ================================================================================ 4. Statement for Month/Year January 2000 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person to Issuer (Check all applicable) |_| Director |X| 10% Owner |_| Officer (give title below) |_| Other (specify below) ________________________________________ ================================================================================ 7. Individual or Joint/Group Filing (Check Applicable Line) |X| Form filed by one Reporting Person |_| Form filed by more than one Reporting Person ================================================================================ * If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v). Page 1 of 5 ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
6. 4. 5. Owner- Securities Acquired (A) or Amount of ship 3. Disposed of (D) Securities Form: 7. Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of 2. Code ---------------------------- Owned at End (D) or Indirect 1. Transaction (Instr. 8) (A) of Month Indirect Beneficial Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership (Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 1,323 A $2.625 3,428,051(1) I The Aries Master Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 1,395 A $2.938 3,428,051(1) I The Aries Master Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/05/00 P 2,000 A $2.688 3,428,051(1) I The Aries Master Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/06/00 P 2,000 A $2.875 3,428,051(1) I The Aries Master Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/07/00 P 1,374 A $3.500 3,428,051(1) I The Aries Master Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 561 A $2.938 3,428,051(1) I Aries Domestic Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 583 A $2.625 3,428,051(1) I Aries Domestic Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/07/00 P 523 A $3.500 3,428,051(1) I Aries Domestic Fund(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 94 A $2.625 3,428,051(1) I Aries Domestic Fund II(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/03/00 P 44 A $2.938 3,428,051(1) I Aries Domestic Fund II(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/04/00 P 2,000 A $2.688 3,428,051(1) I Aries Domestic Fund II(2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 01/07/00 P 103 A $3.500 3,428,051(1) I Aries Domestic Fund II(2) ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Page 2 of 5 FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
9. 10. Number Owner- of ship 2. Deriv- Form of Conver- 5. 7. ative Deriv- 11. sion Number of Title and Amount Secur- ative Nature of Derivative 6. of Underlying 8. ities Secur- of Exer- 4. Securities Date Securities Price Bene- ity: In- cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene- 1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner- Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr. (Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ N/A - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: (1) See Attachment B. (2) See Attachment A ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ Lindsay A. Rosenwald February 7, 2000 - --------------------------------------------- ----------------------- ** Signature of Reporting Person Date Lindsay A. Rosenwald, M.D. Chairman of the Board Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 3 of 5 ATTACHMENT A Reporting Person: Paramount Capital Asset Management, Inc. Issuer: Endorex (DOR) Statement For: January 2000 Paramount Capital Asset Management, Inc. ("PCAM"), the Investment Manager to The Aries Master Fund, a Cayman Islands exempted company (the "Master Fund") is also the General Partner of each of the Aries Domestic Fund, L.P. ("Aries I"), a Delaware limited partnership, and the Aries Domestic Fund II, L.P. ("Aries II"), a Delaware limited partnership, each of which also own securities of the Issuer. Lindsay A. Rosenwald, M.D., is the sole shareholder of Paramount. Paramount and Dr. Rosenwald disclaim beneficial ownership of the securities held by the Partnership and the Fund, except to the extent of their pecuniary interest therein, if any. Page 4 of 5 Attachment B Securities beneficially owned by PCAM are presented on an as-converted basis and consist of the following: 1. 2,191,452 shares of common stock of the Issuer, par value $0.01 per share (the "Common Stock") and warrants to purchase 155,493 shares of Common Stock owned by Master Fund. 2. 983,894 shares of Common Stock and warrants to purchase 79,866 shares of Common Stock owned by Aries I 3. 17,346 shares of Common Stock owned by Aries II Page 5 of 5 -----END PRIVACY-ENHANCED MESSAGE-----